PHARMA
Japan’s NCC & Takeda Enter Research Partnership
The collaboration between the National Cancer Center and Takeda is part of a wider academic-industrial effort to develop new medicines.
CBMG Expands Beijing GMP Facility
CBMG will open a third GMP facility in Beijing to develop their immunotherapy platform, CAR-T.
Green Cross To Build New Cell Therapy Manufacturing Facility In China
The new Green Cross cell therapy manufacturing facility will be located at the Guian New Area in the Guizhou province.
Stem Cell-Based Drug Granted Chinese Patent
The bone marrow-based drug is indicated for the treatment of critical limb ischemia, a common complication of diabetes.
WuXi To Build World’s Largest Mammalian Cell Culture Facility
To be completed in January 2017, the cell culture facility will feature disposable bioreactors.
Daiichi Sankyo Sells Shares Of Sun Pharma
Rocked by FDA warnings and fines, Sun Pharma has been dropped by Japanese pharmaceutical giant Daiichi Sankyo.
Clearbridge & LIDE Launch China’s First CTC Hub
Clearbridge Biomedics has partnered LIDE Biotech to bring circulating tumor cell isolation technology to China.
Sigma-Aldrich Opens Asia-Pac Headquarters In Singapore
The company also announced plans to construct a cGMP distribution center in Tuas by the end of the year.
CiRA & Takeda Undertake US$267 Million iPS Collaboration
The ten-year research collaboration to be hosted at Takeda's Shonan Research Center will focus on developing clinical applications for iPS cells.
